Inotiv Inc 2023 Investor Presentation CRO

Inotiv is a global contract research organization (CRO) offering discovery, safety assessment, and research models services for therapeutic development. The company has completed 14 acquisitions and serves over 3,500 clients globally, with revenues growing from $43.6M in FY'19 to $570.0M guidance for FY'23.